Janus Henderson Group PLC grew its stake in Clorox Company (The) (NYSE:CLX) by 8,008.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,323,475 shares of the company’s stock after buying an additional 1,307,153 shares during the period. Janus Henderson Group PLC owned approximately 1.03% of Clorox Company (The) worth $176,340,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in CLX. American Beacon Advisors Inc. purchased a new position in Clorox Company (The) in the 1st quarter worth approximately $104,000. Parkside Financial Bank & Trust grew its stake in Clorox Company (The) by 3.8% in the 2nd quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after buying an additional 29 shares in the last quarter. Valley National Advisers Inc. grew its stake in Clorox Company (The) by 0.6% in the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after buying an additional 5 shares in the last quarter. Blue Chip Partners Inc. grew its stake in Clorox Company (The) by 3.9% in the 2nd quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock worth $125,000 after buying an additional 35 shares in the last quarter. Finally, Sun Life Financial INC grew its stake in Clorox Company (The) by 10,344.4% in the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after buying an additional 931 shares in the last quarter. 71.33% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Janus Henderson Group PLC Grows Holdings in Clorox Company (The) (CLX)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/10/08/janus-henderson-group-plc-grows-holdings-in-clorox-company-the-clx.html.

Clorox Company (NYSE:CLX) traded up 0.14% during midday trading on Friday, reaching $129.14. 1,096,307 shares of the company were exchanged. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76. The company has a 50-day moving average of $134.59 and a 200 day moving average of $134.61. The firm has a market capitalization of $16.67 billion, a PE ratio of 24.21 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. Clorox Company (The)’s revenue was up 2.9% on a year-over-year basis. During the same period last year, the company earned $1.30 earnings per share. Equities analysts predict that Clorox Company will post $5.66 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be given a $0.84 dividend. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a yield of 2.60%. Clorox Company (The)’s dividend payout ratio is presently 63.04%.

A number of brokerages have recently weighed in on CLX. Jefferies Group LLC restated a “hold” rating and issued a $137.00 price objective (up from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Royal Bank Of Canada restated a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Zacks Investment Research lowered shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. BidaskClub lowered shares of Clorox Company (The) from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. Finally, BMO Capital Markets restated an “outperform” rating on shares of Clorox Company (The) in a report on Tuesday, September 12th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $127.39.

In related news, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP James E. Foster sold 9,861 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the sale, the executive vice president now owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 21,242 shares of company stock valued at $2,944,449. 1.00% of the stock is owned by corporate insiders.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.